137 related articles for article (PubMed ID: 24364871)
1. Enhanced oral bioavailability of the antiretroviral efavirenz encapsulated in poly(epsilon-caprolactone) nanoparticles by a spray-drying method.
Tshweu L; Katata L; Kalombo L; Chiappetta DA; Hocht C; Sosnik A; Swai H
Nanomedicine (Lond); 2014; 9(12):1821-33. PubMed ID: 24364871
[TBL] [Abstract][Full Text] [Related]
2. Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability [corrected].
Chiappetta DA; Hocht C; Taira C; Sosnik A
Nanomedicine (Lond); 2010 Jan; 5(1):11-23. PubMed ID: 20025460
[TBL] [Abstract][Full Text] [Related]
3. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation.
Patel GV; Patel VB; Pathak A; Rajput SJ
Drug Dev Ind Pharm; 2014 Jan; 40(1):80-91. PubMed ID: 23323843
[TBL] [Abstract][Full Text] [Related]
4. Poly(ε-caprolactone), Eudragit® RS 100 and poly(ε-caprolactone)/Eudragit® RS 100 blend submicron particles for the sustained release of the antiretroviral efavirenz.
Seremeta KP; Chiappetta DA; Sosnik A
Colloids Surf B Biointerfaces; 2013 Feb; 102():441-9. PubMed ID: 23010128
[TBL] [Abstract][Full Text] [Related]
5. An oral formulation of efavirenz-loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile.
Kumar P; Lakshmi YS; Kondapi AK
HIV Med; 2017 Aug; 18(7):452-462. PubMed ID: 28000390
[TBL] [Abstract][Full Text] [Related]
6. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
7. Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles.
Mady FM; Shaker MA
Int J Nanomedicine; 2017; 12():7405-7417. PubMed ID: 29066891
[TBL] [Abstract][Full Text] [Related]
8. Anti HIV nanoemulsion formulation: optimization and in vitro-in vivo evaluation.
Kotta S; Khan AW; Ansari SH; Sharma RK; Ali J
Int J Pharm; 2014 Feb; 462(1-2):129-34. PubMed ID: 24374067
[TBL] [Abstract][Full Text] [Related]
9. Preparation and investigation of high solid content PTX-loaded nanoparticles dispersion via nanoprecipitation method.
Xiang Y; Xiao M; Han S; Xu S; Cao Y; Lv Z; Liu J; Liu J; Deng L; Dong A
J Biomater Sci Polym Ed; 2014; 25(11):1144-58. PubMed ID: 24894948
[TBL] [Abstract][Full Text] [Related]
10. Correlation between microstructure and bioequivalence in anti-HIV drug efavirenz.
Fandaruff C; Segatto Silva MA; Galindo Bedor DC; de Santana DP; Rocha HV; Rebuffi L; Azanza Ricardo CL; Scardi P; Cuffini SL
Eur J Pharm Biopharm; 2015 Apr; 91():52-8. PubMed ID: 25661587
[TBL] [Abstract][Full Text] [Related]
11. Oral pharmacokinetics of the anti-HIV efavirenz encapsulated within polymeric micelles.
Chiappetta DA; Hocht C; Taira C; Sosnik A
Biomaterials; 2011 Mar; 32(9):2379-87. PubMed ID: 21186055
[TBL] [Abstract][Full Text] [Related]
12. Noncovalent PEG Coating of Nanoparticle Drug Carriers Improves the Local Pharmacokinetics of Rectal Anti-HIV Microbicides.
Nunes R; Araújo F; Barreiros L; Bártolo I; Segundo MA; Taveira N; Sarmento B; das Neves J
ACS Appl Mater Interfaces; 2018 Oct; 10(41):34942-34953. PubMed ID: 30234288
[TBL] [Abstract][Full Text] [Related]
13. Poly (ε-caprolactone) nanocapsules for oral delivery of raloxifene: process optimization by hybrid design approach, in vitro and in vivo evaluation.
Aditya N; Ravi PR; Avula US; Vats R
J Microencapsul; 2014; 31(5):508-18. PubMed ID: 24697167
[TBL] [Abstract][Full Text] [Related]
14. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
Jin X; Huang A; Ping Q; Cao F; Su Z
Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
[TBL] [Abstract][Full Text] [Related]
15. Spray-dried didanosine-loaded polymeric particles for enhanced oral bioavailability.
Seremeta KP; Tur MI; Pérez SM; Höcht C; Taira C; López Hernández OD; Sosnik A
Colloids Surf B Biointerfaces; 2014 Nov; 123():515-23. PubMed ID: 25444665
[TBL] [Abstract][Full Text] [Related]
16. Oral delivery of capsaicin using MPEG-PCL nanoparticles.
Peng W; Jiang XY; Zhu Y; Omari-Siaw E; Deng WW; Yu JN; Xu XM; Zhang WM
Acta Pharmacol Sin; 2015 Jan; 36(1):139-48. PubMed ID: 25434988
[TBL] [Abstract][Full Text] [Related]
17. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
18. Rifampicin-loaded 'flower-like' polymeric micelles for enhanced oral bioavailability in an extemporaneous liquid fixed-dose combination with isoniazid.
Moretton MA; Hocht C; Taira C; Sosnik A
Nanomedicine (Lond); 2014 Aug; 9(11):1635-50. PubMed ID: 24410279
[TBL] [Abstract][Full Text] [Related]
19. Long-lasting anti-platelet activity of cilostazol from poly(ε-caprolactone)-poly(ethylene glycol) blend nanocapsules.
Gomes MLS; da Silva Nascimento N; Borsato DM; Pretes AP; Nadal JM; Novatski A; Gomes RZ; Fernandes D; Farago PV; Zanin SMW
Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():694-702. PubMed ID: 30423756
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs.
Cunha-Reis C; Machado A; Barreiros L; Araújo F; Nunes R; Seabra V; Ferreira D; Segundo MA; Sarmento B; das Neves J
J Control Release; 2016 Dec; 243():43-53. PubMed ID: 27664327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
